EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Human umbilical cord-derived mesenchymal stem cells alleviate autoimmune hepatitis by inhibiting hepatic ferroptosis

Yaqin Li, Bing Liu, Guoxin Hu, Tao Zhou, Xuanqiu He, Ling Guo, Luoshi Zhang, Weizhao Tong, Yihua Chen, Youhua Xu, Guangdong Tong, Wei V Zheng iD

PLOS One · 2025

DOI: 10.1371/journal.pone.0337060 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Yaqin Li und 11 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Chinese Medicine, Macau University of Science and Technology, Taipa, Macao, People's Republic of China. Hauptthemen laut MEDLINE: Ferroptosis, Mesenchymal Stem Cells, Umbilical Cord, Mesenchymal Stem Cell Transplantation. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Shenzhen Science and Technology Program, Shenzhen Biomedical Industry Major Public Service Platform and Core Technology Research Special Support Plan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Autoimmune hepatitis (AIH) is a liver disease marked by immune-mediated hepatocyte damage. Current treatments have variable patient responses and considerable side effects, highlighting the need for alternative therapies. Human umbilical cord-derived mesenchymal stem cells (hUC-MSCs) have shown therapeutic potential in liver diseases, but their mechanisms in AIH remain unclear.

Methods

A Concanavalin A (ConA)-induced AIH-like mouse model was used to assess the therapeutic effects of hUC-MSCs. Survival, liver function-related serum marker expression, histopathology, and apoptosis were evaluated. Metabolomic profiling and ferroptosis-related markers were analyzed to uncover potential mechanisms.

Results

In ConA-induced AIH-like mouse model challenged with a lethal dose of ConA, hUC-MSC treatment significantly ameliorated liver tissue damage and serum liver function parameters, alleviated hepatocyte apoptosis, and improved survival. Metabolomic and ontology analyses of mouse liver tissue samples revealed that hUC-MSCs treatment altered the levels of metabolites (Glu derivatives and peptides) functionally associated with ferroptosis-related pathways. hUC-MSCs partially reversed ConA-induced malondialdehyde (MDA), oxidized glutathione (GSSG), glutamate, and Fe 2+ , while restoring reduced glutathione (GSH). Expression of COX2 was downregulated, whereas key ferroptosis suppressors, SLC7A11, GPX4, and FTH1, were upregulated following hUC-MSC treatment.

Conclusions

Based on the above evidence, we propose that hUC-MSCs may ameliorate ConA-induced liver injury in mice, potentially through modulation of ferroptosis-related pathways, and we support further investigation of hUC-MSCs as potential treatments for AIH. We believe that further in-depth studies are still needed to elaborate on the detailed regulatory mechanisms of MSCs on the ferroptosis pathway during the treatment of AIH.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerroptosisMesenchymal Stem CellsUmbilical CordMesenchymal Stem Cell TransplantationHepatitis, AutoimmuneLiverAnimalsHumansMiceDisease Models, AnimalConcanavalin AApoptosisMaleMetabolomicsHepatocytes

Substanzen

Concanavalin A

Autor:innen und Institutionen

  • Faculty of Chinese Medicine, Macau University of Science and Technology, Taipa, Macao, People's Republic of China.
  • Department of Infectious Disease, Peking University Shenzhen Hospital, Shenzhen, Guangdong, People's Republic of China.
  • Department of Hematology, Peking University Shenzhen Hospital, Shenzhen, Guangdong, People's Republic of China.
  • Intervention and Cell Therapy Center, Peking University Shenzhen Hospital, Shenzhen, Guangdong, People's Republic of China.
  • Department of Liver Disease, Shenzhen Traditional Chinese Medicine Hospital, The Fourth Clinical Medical College of Guangzhou University of Chinese Medicine, Shenzhen, Guangdong, People's Republic of China.

ORCID-Profile: Wei V Zheng

Förderung

  • National Natural Science Foundation of China
  • Shenzhen Science and Technology Program
  • Shenzhen Biomedical Industry Major Public Service Platform and Core Technology Research Special Support Plan
  • BYD Charity Foundation
  • Medical Scientific Research Foundation of Guangdong Province
  • Peking University Shenzhen Hospital Research Foundation

Zitieren

APA

Li, Y., Liu, B., Hu, G., Zhou, T., He, X., Guo, L., Zhang, L., Tong, W., Chen, Y., Xu, Y., Tong, G., & Zheng, W. V. (2025). Human umbilical cord-derived mesenchymal stem cells alleviate autoimmune hepatitis by inhibiting hepatic ferroptosis. PLOS One. https://doi.org/10.1371/journal.pone.0337060

Vancouver

Li Y, Liu B, Hu G, Zhou T, He X, Guo L, et al. Human umbilical cord-derived mesenchymal stem cells alleviate autoimmune hepatitis by inhibiting hepatic ferroptosis. PLOS One. 2025. doi:10.1371/journal.pone.0337060

BibTeX
@article{Li2025,
  author = {Li, Yaqin and Liu, Bing and Hu, Guoxin and Zhou, Tao and He, Xuanqiu and Guo, Ling and Zhang, Luoshi and Tong, Weizhao and Chen, Yihua and Xu, Youhua and Tong, Guangdong and Zheng, Wei V},
  title = {Human umbilical cord-derived mesenchymal stem cells alleviate autoimmune hepatitis by inhibiting hepatic ferroptosis},
  journal = {PLOS One},
  year = {2025},
  doi = {10.1371/journal.pone.0337060}
}
Kostenlos starten →